Form 8-K - Current report:
SEC Accession No. 0001193125-23-196808
Filing Date
2023-07-28
Accepted
2023-07-28 07:11:00
Documents
22
Period of Report
2023-07-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d507671d8k.htm   iXBRL 8-K 36324
2 EX-99.1 d507671dex991.htm EX-99.1 24875
3 EX-99.2 d507671dex992.htm EX-99.2 14557
7 GRAPHIC g507671ex99_2p1g1.jpg GRAPHIC 416043
8 GRAPHIC g507671ex99_2p2g1.jpg GRAPHIC 629672
9 GRAPHIC g507671ex99_2p3g1.jpg GRAPHIC 158491
10 GRAPHIC g507671ex99_2p4g1.jpg GRAPHIC 310862
11 GRAPHIC g507671ex99_2p5g1.jpg GRAPHIC 299543
12 GRAPHIC g507671ex99_2p6g1.jpg GRAPHIC 219489
13 GRAPHIC g507671ex99_2p7g1.jpg GRAPHIC 207534
14 GRAPHIC g507671ex99_2p8g1.jpg GRAPHIC 142021
  Complete submission text file 0001193125-23-196808.txt   3498863

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA biib-20230728.xsd EX-101.SCH 2859
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE biib-20230728_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biib-20230728_pre.xml EX-101.PRE 10818
16 EXTRACTED XBRL INSTANCE DOCUMENT d507671d8k_htm.xml XML 3203
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 231120208
SIC: 2836 Biological Products, (No Diagnostic Substances)